LYLY TRAN

Allopathic & Osteopathic Physicians|Family Medicine ST PETERSBURG, FL NPI 1598059784

General Payments — all program years on this page

$717.91

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 35
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $513.19 across 23 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $513.1923

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $17.641
2020 $13.201
2022 $16.381
2023 $157.509
2024 $513.1923

Records — PY2024 (23)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1082152823 Dynavax Technologies Corporation $21.05 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096750707 Novo Nordisk Inc $22.95 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096852964 Novo Nordisk Inc $15.52 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096857901 Novo Nordisk Inc $21.54 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097725140 Novo Nordisk Inc $14.04 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104420081 AstraZeneca Pharmaceuticals LP $13.87 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105647464 AstraZeneca Pharmaceuticals LP $14.36 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106239152 ABBVIE INC. $33.63 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106239154 ABBVIE INC. $28.40 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106239156 ABBVIE INC. $18.41 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106239158 ABBVIE INC. $20.42 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106239160 ABBVIE INC. $20.27 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114934354 Exact Sciences Corporation $24.50 12/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116033265 GlaxoSmithKline, LLC. $28.34 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117401468 Amgen Inc. $14.33 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131038110 PFIZER INC. $15.23 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131672835 PFIZER INC. $16.38 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135136552 Lilly USA, LLC $19.36 05/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135151686 Lilly USA, LLC $27.15 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135161561 Lilly USA, LLC $25.62 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139275076 Astellas Pharma US Inc $31.86 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139289558 Astellas Pharma US Inc $21.44 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151133987 Phathom Pharmaceuticals, Inc. $44.52 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.